Logo image of ARL

AMERICAN REALTY INVESTORS IN (ARL) Stock Fundamental Analysis

NYSE:ARL - New York Stock Exchange, Inc. - US0291741090 - Common Stock - Currency: USD

13.86  +0.36 (+2.67%)

Fundamental Rating

2

ARL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. ARL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ARL has reported negative net income.
ARL had a negative operating cash flow in the past year.
Of the past 5 years ARL 4 years were profitable.
ARL had negative operating cash flow in 4 of the past 5 years.
ARL Yearly Net Income VS EBIT VS OCF VS FCFARL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

The Return On Assets of ARL (-1.60%) is comparable to the rest of the industry.
The Return On Equity of ARL (-2.77%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.6%
ROE -2.77%
ROIC N/A
ROA(3y)10.66%
ROA(5y)6.22%
ROE(3y)20.96%
ROE(5y)12%
ROIC(3y)N/A
ROIC(5y)N/A
ARL Yearly ROA, ROE, ROICARL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

In the last couple of years the Profit Margin of ARL has declined.
ARL has a Gross Margin of 44.12%. This is in the better half of the industry: ARL outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of ARL has declined.
ARL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-19.84%
PM growth 5Y-44.01%
GM growth 3Y-8.7%
GM growth 5Y-2.48%
ARL Yearly Profit, Operating, Gross MarginsARL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600 800

5

2. Health

2.1 Basic Checks

ARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARL has less shares outstanding
ARL has more shares outstanding than it did 5 years ago.
ARL has a better debt/assets ratio than last year.
ARL Yearly Shares OutstandingARL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ARL Yearly Total Debt VS Total AssetsARL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that ARL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.15, ARL perfoms like the industry average, outperforming 43.33% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that ARL is not too dependend on debt financing.
ARL has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: ARL outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC6.98%
ARL Yearly LT Debt VS Equity VS FCFARL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

ARL has a Current Ratio of 2.94. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.94, ARL is doing good in the industry, outperforming 75.00% of the companies in the same industry.
ARL has a Quick Ratio of 2.94. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ARL (2.94) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 2.94
ARL Yearly Current Assets VS Current LiabilitesARL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

0

3. Growth

3.1 Past

The earnings per share for ARL have decreased strongly by -133.72% in the last year.
The earnings per share for ARL have been decreasing by -53.09% on average. This is quite bad
The Revenue has decreased by -0.75% in the past year.
ARL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.03% yearly.
EPS 1Y (TTM)-133.72%
EPS 3Y-24.02%
EPS 5Y-53.09%
EPS Q2Q%-700.54%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-5.05%
Revenue growth 5Y-16.03%
Sales Q2Q%-7.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARL Yearly Revenue VS EstimatesARL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ARL Yearly EPS VS EstimatesARL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARL Price Earnings VS Forward Price EarningsARL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ARL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.31
ARL Per share dataARL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ARL!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REALTY INVESTORS IN

NYSE:ARL (2/21/2025, 8:04:00 PM)

13.86

+0.36 (+2.67%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-19 2025-03-19
Inst Owners3.26%
Inst Owner Change7.29%
Ins Owners0.22%
Ins Owner Change0%
Market Cap223.84M
Analysts0
Price TargetN/A
Short Float %1.38%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.54
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 0.37
EV/EBITDA 54.31
EPS(TTM)-1.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.81
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS3.05
BVpS37.29
TBVpS37.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.6%
ROE -2.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.12%
FCFM N/A
ROA(3y)10.66%
ROA(5y)6.22%
ROE(3y)20.96%
ROE(5y)12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-19.84%
PM growth 5Y-44.01%
GM growth 3Y-8.7%
GM growth 5Y-2.48%
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 27.55
Cap/Depr 288.2%
Cap/Sales 80.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.94
Quick Ratio 2.94
Altman-Z 1.15
F-Score2
WACC6.98%
ROIC/WACCN/A
Cap/Depr(3y)107.65%
Cap/Depr(5y)96.41%
Cap/Sales(3y)35.2%
Cap/Sales(5y)30.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.72%
EPS 3Y-24.02%
EPS 5Y-53.09%
EPS Q2Q%-700.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-5.05%
Revenue growth 5Y-16.03%
Sales Q2Q%-7.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-182.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-106.61%
OCF growth 3YN/A
OCF growth 5YN/A